CMC Biologics, a provider of fully integrated biopharmaceutical development and manufacturing services, has named Claes Glassell as the new CEO.
Subscribe to our email newsletter
Glassell joined the CMC Biologics board of directors in 2005.
Most recently, Glassell worked as CEO of Cerus Corporation and prior to that as president of Cambrex Corp.
CMC Biologics CEO Mads Laustsen said as one of the founders of CMC Claes brings the best skills and experience to ensure CMC’s continued growth.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.